000			03940nam a22002897a 4500
001			20241030200025.0
003			OCoLC
005			20241030201146.0
008			241030b |||||||| |||| 00| 0 eng d
020			_a 978-3-031-34846-4
020			_a 978-3-031-34847-1 (eBook)
022			_a0942-5373
022			_a2197-4187 (electronic)
040			_cddc
041			_aEnglish
100			_qBranislav Jeremić
222			_aadenocarcinoma advanced non-small-cell lung amifostine angiogenesis bevacizumab brachytherapy brain metastases CALGB carboplatin cell lung cancer chemoradiation Chest cisplatin Clin Oncol combination concurrent chemotherapy CT disease docetaxel dose escalation effect EGFR endobronchial erlotinib esophagitis etoposide evaluation fractions gefitinib gemcitabine grade growth factor Gy hyperfractionated imaging improved induction chemotherapy inhibitor Int J Radiat Jeremic lesions locally advanced lung cancer NSCLC lung tumors lymph node median survival mediastinal metastases months non-small cell lung non-small-cell lung cancer normal tissue Oncol Biol Phys outcome overall survival paclitaxel patients with stage PCI pemetrexed PET phase II study phase III trial pleural prognostic prophylactic cranial irradiation pulmonary Radiat Oncol Biol Radiation Oncology radiation pneumonitis Radiation Therapy Oncology Radiother radiotherapy randomized trial recurrence regimens reported resection RT RTOG scans SCLC small cell small-cell lung cancer stent surgery surgical survival rates target volume thoracic radiation therapy thoracic radiotherapy tomography toxicity treatment planning tumor unresectable versus vinorelbine
245			_aAdvances in Radiation Oncology in Lung Cancer.
250			_aThird Edition
260			_aSchool of Medicine University of Kragujevac Kragujevac, Serbia | _b Springer Nature Switzerland AG | _c2023
300			_a1128 Pages
490			_aMedical Radiology Radiation Oncology
520			_aAlthough decades of laboratory and clinical research have led to incremental improvement in treatment outcome, lung cancer remains one of the most deadly diseases. In the second, completely updated edition of this comprehensive book, many of the world’s leading lung cancer specialists discuss the recent advances in the radiation oncology of lung cancer and reflect on the latest research findings. The first three sections cover the basic science of lung cancer, clinical investigations, including histology and staging, and a wide range of fundamental treatment considerations. Current treatment strategies for nonsmall cell and small cell lung cancer are then explained and evaluated in detail, with due attention to novel approaches that promise further improvements in outcome. The various types of treatment-related toxicity are discussed, and quality of life studies and prognostic factors are also considered. After evaluating the latest technological and biological advances, including IMRT, IMAT, cyber knife treatment, and tomotherapy, the book concludes by thorough consideration of specific aspects of clinical research in lung cancer.
600			_xMedical / Allied Health Services / Imaging Technologies, Medical / Biochemistry, Medical / Clinical Medicine, Medical / Oncology / General, Medical / Pulmonary & Thoracic Medicine, Medical / Radiology, Radiotherapy & Nuclear Medicine, Medical / Surgery / Cardiothoracic, Oncology, Radiology, Respiratory organs—Diseases, Surgery, Electronic books, Lungs -- Cancer -- Radiotherapy, Medical / Diagnostic Imaging / General, Medical / Internal Medicine, Medical / Oncology / Lung Cancer, Medical / Surgery / General, Chest -- Surgery, Imaging -- Radiology, Medical radiology, Medicine, Medicine and Public Health, Pneumology, Pneumology/Respiratory System, Radiotherapy, Respiratory organs -- Diseases.
856			_u https://doi.org/10.1007/978-3-031-34847-1
942			_2ddc _cEB _n0
999			_c29472 _d29472